Ro's weight loss pricing separates a membership fee ($39-$45 first month, then commonly $145-$149/month) from medication cost, which varies by product and dose — the combined total is what actually matters for comparison.
Luma Health's compounded semaglutide ($197/month) and tirzepatide ($297/month) fold everything into one flat number for direct comparison.
Ro's pricing structure is one of the more commonly misunderstood in the GLP-1 telehealth space, since the membership fee and medication price are separate line items rather than one all-in number. Here's how it actually breaks down.
The Membership Fee
Ro's Body Program membership is commonly reported at $39-$45 for the first month, then $145-$149/month on a month-to-month basis, or as low as $74/month with an annual prepay. This fee covers provider consultations, ongoing messaging access, coaching, and insurance-coverage coordination — but not the medication itself.
Medication Costs by Product
On top of membership, medication is billed separately and varies by product: Wegovy pill cash-pay pricing has started around $149/month for lower doses; the Wegovy pen has run $199/month during promotional periods before reverting to $349/month; and Zepbound vials, accessed through Ro's LillyDirect integration, commonly run $299-$449/month by dose. If your insurance covers your specific medication, your cost can drop to a much smaller copay.
Combining membership and medication, cash-pay totals have been reported around $294/month for a starting-dose Wegovy pill, and up to $544-$648/month for a mid-to-higher-dose Zepbound vial. With insurance covering the medication, total cost can drop to roughly $170/month (membership plus a small copay) — which is where Ro's model delivers its strongest value.
How This Compares to Flat-Rate Compounded Pricing
Luma Health's compounded semaglutide and tirzepatide are priced as one number — $197/month and $297/month respectively, regardless of dose, with no separate membership fee. For cash-pay patients without insurance covering brand medication, this flat structure is typically less expensive than Ro's combined membership-plus-medication total, particularly at higher therapeutic doses.
Which Pricing Structure Fits You
- Have insurance likely to cover your specific medication
- Want dedicated insurance-navigation support included
- Specifically want FDA-approved brand-name product
- Are paying cash without brand-medication insurance coverage
- Want one predictable number, not separate line items
- Don't need insurance-concierge support
One number,
no separate membership fee
Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included.
Get Started → Or start your free health assessmentFrequently Asked Questions
No. The membership fee (commonly $145-$149/month) covers provider access, coaching, and insurance coordination; medication is billed separately and varies by product and dose.
If your insurance covers your specific medication, your cost can drop to a small copay on top of the membership fee — the scenario where Ro's total cost is lowest.
Through Ro's LillyDirect integration, Zepbound vials commonly run $299-$449/month by dose, on top of the separate membership fee, for cash-pay patients.
Yes, prepaying annually can bring the membership fee down to as low as $74/month, though this requires the larger upfront commitment.
For cash-pay patients without insurance coverage, typically no — flat-rate compounded options tend to be less expensive than Ro's combined membership-plus-medication total, especially at higher doses.
Your insurance status is the biggest factor. Insured patients with covered medication pay the least; cash-pay patients pay the membership fee plus full medication cost.
References
- Ro. Weight loss program pricing. Ro.co. 2026. Ro.co
- Eli Lilly and Company. Zepbound (tirzepatide) cost and self-pay information. Lilly.com. 2026. pricinginfo.lilly.com
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database